Filing Details
- Accession Number:
- 0001209191-15-060981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-15 17:54:27
- Reporting Period:
- 2015-07-14
- Filing Date:
- 2015-07-15
- Accepted Time:
- 2015-07-15 17:54:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 270119051 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1417977 | C Leonard Debenedictis | Zeltiq Aesthetics Inc. C/O 4698 Willow Road Suite 100 Pleasanton CA 94588 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-14 | 1,563 | $6.50 | 51,959 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-07-14 | 1,563 | $30.00 | 50,396 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-07-14 | 1,563 | $0.00 | 1,563 | $6.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
43,333 | 2022-10-07 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- 25% of the total number of shares subject to the option vested on October 8, 2013, and the remainder vests in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.